Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
João Lobo(Universidade do Porto), Carla Bartosch(Universidade do Porto), Esther Oliva(Agostino Gemelli University Polyclinic), José R. Vizcaíno(Centro Hospitalar do Porto), Manuela Pinheiro(Instituto Português de Oncologia Francisco Gentil), Micaela Freitas(Instituto Português de Oncologia Francisco Gentil), Cármen Jerónimo(Universidade do Porto), Carla Pinto(Instituto Português de Oncologia Francisco Gentil), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
December 3, 2016
Cited by 15
Related Papers
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
|The Journal of Pathology|2019|401
Renal Cell Carcinoma in Tuberous Sclerosis Complex
|The American Journal of Surgical Pathology|2014|274
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
|European Urology|2014|253
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
|European Urology|2019|244
Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 Rearrangement
|The American Journal of Surgical Pathology|2012|199